TransCode Therapeutics, Inc. RNAZ

Set alert

Price alert · RNAZ

All alert types
1.59 USD -0.04 -2.45%

As of Nov 3, 1:01 PM ET

Bid
1.56 × 23
Ask
1.59 × 1
1.50 Day range 1.61
1.50 52-week range 12.60
YTD
-76.72%
1 year
-84.87%
Open
1.58
Prev close
1.63
Mkt cap
26.33M
Vol
17.32K
Avg vol
53.91K
EPS
-52.06
P/E
0.00
Div yield
0.00%
More statistics
Low
1.50
High
1.61
Forward P/E
-5.97
Beta
0.65
Short ratio
0.50
Inst. own
1.99%
Dividend
0.00
Ex-div date
Earnings
Aug 14, 2024
50-d avg
13.50
200-d avg
20.41
1y target
20.00

MAX chart

Chart tools
Interval

Chart is warming up

The all-time price history for RNAZ has not been loaded yet. Try again in a moment.

Analyst view

Consensus: buy

Buy
Price target (mean) 20.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy0
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 1
  • 1 month ago 1
  • 2 months ago 1
  • 3 months ago 1

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

RNAZ analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-3.21-3.21 – -3.21-627.33+99.5%300.00K0.0%1
Next quarter0.000.00 – 0.00-21.450.0%00.0%0
Current year-4.76-4.76 – -4.76-3,419.13+99.9%300.00K0.0%1
Next year-4.37-4.37 – -4.37-4.76+8.2%0-100.0%1

Upgrades and downgrades

The latest rating changes

RNAZ analyst upgrades and downgrades
DateFirmActionFromTo
Nov 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 24, 2024HC Wainwright & Co.ReiteratedBuyBuy
Sep 6, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 29, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 16, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 16, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 3, 2024HC Wainwright & Co.ReiteratedBuyBuy